Retracted: Serum IL-37 Level Is Associated with Rheumatoid Arthritis and Disease Activity: A Meta-Analysis. [PDF]
Biomed Res Int, 2023 International BR.
europepmc +1 more source
Molecular Oncology, EarlyView.A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath +13 more
wiley +1 more source
Early Postpartum IL-10 and IL-37 Concentrations in Women with Gestational Diabetes Mellitus. [PDF]
Med Sci MonitGorczyca K +3 more
europepmc +1 more source
Novel insights into IL-37: an anti-inflammatory cytokine with emerging roles in anti-cancer process. [PDF]
Front Immunol, 2023 Gu M, Jin Y, Gao X, Xia W, Xu T, Pan S.
europepmc +1 more source
YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma
Molecular Oncology, EarlyView.The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy +9 more
wiley +1 more source
IL‑37 suppresses macrophage ferroptosis to attenuate diabetic atherosclerosis via the NRF2 pathway. [PDF]
Exp Ther Med, 2023 Xu J, Han X, Xia N, Zhao Q, Cheng Z.
europepmc +1 more source
Lightning Researcher Is New Peter T. Paul Chair in Space Sciences at UNH [PDF]
, 2014 Sims, David
core +1 more source
Emerging role of ARHGAP29 in melanoma cell phenotype switching
Molecular Oncology, EarlyView.This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster +3 more
wiley +1 more source
Serum Dysregulation of IL-36, IL-37, and IL-38 in Pyoderma Gangrenosum: Clinical Correlations and Implications for IL-36R-Targeted Therapy. [PDF]
Int J Mol SciŁyko M +5 more
europepmc +1 more source
Regulatory Mechanism of the IL-33-IL-37 Axis via Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis. [PDF]
Int J Mol Sci, 2023 Tsuji G +5 more
europepmc +1 more source